Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.665 USD | -6.02% | -2.86% | +8.36% |
05-09 | RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk | MT |
05-08 | Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.36% | 544M | |
+9.48% | 115B | |
+11.68% | 106B | |
-2.42% | 21.96B | |
-14.18% | 21.87B | |
-5.29% | 19.21B | |
-3.83% | 18.08B | |
-38.29% | 17.71B | |
+7.18% | 14.32B | |
+35.68% | 12.42B |
- Stock Market
- Equities
- IGMS Stock
- News IGM Biosciences, Inc.
- Transcript : IGM Biosciences, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-14-2021 08